Showing results (1-10 of 994) with videos related to

Sort By:
Pageof 100
The Lancet. Gastroenterology & Hepatology|August 19, 2023
NASH drug treatment development: challenges and lessonsHerbert Tilg, Christopher D Byrne, Giovanni Targher
The Lancet. Gastroenterology & Hepatology|May 7, 2021
Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approachGiovanni Targher, Herbert Tilg, Christopher D Byrne
Gut|January 16, 2024
MASLD: a systemic metabolic disorder with cardiovascular and malignant complicationsGiovanni Targher, Christopher D Byrne, Herbert Tilg
Gut|November 26, 2024
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonistsGiovanni Targher, Alessandro Mantovani, Christopher D Byrne, et al.
Gut|September 17, 2020
Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individualsAlessandro Mantovani, Graziana Petracca, Giorgia Beatrice, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 12, 2025
Risk of Serious Bacterial and Non-Bacterial Infections in People With MASLDGiovanni Targher, Herbert Tilg, Luca Valenti
Liver International : Official Journal of the International Association for the Study of the Liver|January 19, 2019
Association between non-alcoholic fatty liver disease and risk of atrial fibrillation in adult individuals: An updated meta-analysisAlessandro Mantovani, Marco Dauriz, Damiano Sandri, et al.
Journal of Hepatology|April 29, 2015
NAFLD: a multisystem diseaseChristopher D Byrne, Giovanni Targher
Pageof 100